Stay updated with breaking news from Philippe Funfrock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHOTM Transient Expression System.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel ... AKAMPIONApril 12, 2021 GMT - Company forms international consortium with ProteoGenix SAS and Amsterdam UMC Schlieren (Zurich Area), Switzerland – April 12, 2021 – ImmunOs Therapeutics AG, a Swiss bio-technology company developing a new class of biologics for the treatment of cancer and autoimmune diseases, announced today that is has received public funding from the European Union’s Eurostars-2 Progra...